Herschel S. Nachlis
Research Assistant Professor of GovernmentPolicy Fellow, Rockefeller Center for Public Policy
Research Assistant Professor of Government
Policy Fellow, Rockefeller Center for Public Policy
Herschel Nachlis is a Research Assistant Professor in the Department of Government, and a Policy Fellow in the Nelson A. Rockefeller Center for Public Policy and the Social Sciences.
[show more]
He received his Ph.D. and M.A. in Politics and Social Policy from Princeton University, and B.A. in Political Science from Macalester College.
He studies and teaches American politics and public law, focusing on institutions, health, and social policy. His research examines the political development of mental health policy, variation in the diagnosis and treatment of health issues caused by political factors and public policies, and representation and inequality in American policymaking and law.
His research interests include the politics of health and disease more generally, agencies and regulation, diversity and representation in legal and bureaucratic institutions, constitutional development and judicial policymaking, and American political development.
His research has received the Robert C. Wood Paper Prize from the New England Political Science Association, and his teaching has received the George Kateb Prize from Princeton's Department of Politics. Previously, he was an Assistant Professor of Government at Franklin & Marshall College and a Postdoctoral Fellow in Dartmouth's Rockefeller Center for Public Policy.
[show less]
Department(s):
Government
Center(s):
The Nelson A. Rockefeller Center for Public Policy
Education:
Ph.D. Princeton University
M.A. Princeton University
B.A. Macalester College
Selected Publications
"Watch this FDA hearing on Thursday. It'll help ease your Covid-19 anxieties," STAT, October 21, 2020.
"The FDA's Evolving COVID-19 Emergency Use Authorizations: How The Convalescent Plasma Authorization Can Inform Future Vaccine and Therapeutic EUAs," Health Affairs Blog, October 20, 2020, DOI: 10.1377/hblog20201016.659416.
"Emergency Use Authorizations During the COVID-19 Pandemic: Lessons From Hydroxychloroquine for Vaccine Authorization and Approval," JAMA: The Journal of the American Medical Association 324, no. 13 (2020): 1282-1283 (with Kyle Thomson).
"Crisis Governance, COVID-19, and American Policy History," Clio 29, no. 2 (2020): 6, 19-24.
"This is why the federal government has a hard time regulating prescription opioids," The Washington Post / Monkey Cage, January 13, 2019.
"Pockets of Weakness in Strong Institutions: Post-Marketing Regulation, Psychopharmaceutical Drugs, and Medical Autonomy, 1938-1982," Studies in American Political Development 32, no. 2 (2018): 257-291.
Review of David Vogel, The Politics of Precaution: Regulating Health, Safety, and Environmental Risks in Europe and the United States (Princeton: Princeton University Press, 2012), Law and Politics Book Review 23, no. 3 (2014): 135-140.